AIM: To isolate nestin-positive progenitor cells from human fetal pancreas and to detect their surface markers and their capability of proliferation and differentiation into pancreatic islet endocrine cells in vitro. METHODS: Islet-like cell clusters (ICCs) were isolated from human fetal pancreas by using collagenase digestion. The free-floating ICCs were handpicked and cultured in a new dish. After the ICCs developed into monolayer epithelium-like cells, they were passaged and induced for differentiation. Reverse transcription polymerase chain reaction (RT-PCR), immunofluorescence stain, fluorescence-activated cell sorting (FACS) and radioimmunoassay (RIA) were used to detect the expression of cell markers. RESULTS: (1) The monolayer epithelium-like cells had highly proliferative potential and could be passaged more than 16 times in vitro; (2) RT-PCR analysis and immunofluorescence stain showed that these cells expressed both nestin and ABCG2, two of stem cell markers; (3) FACS analysis revealed that CD44, CD90 and CD147 were positive, whereas CD34, CD38, CD45, CD71, CD117, CD133 and HLA-DR were negative on the nestin-positive cells; (4) RT-PCR analysis showed that the mRNA expression of insulin, glucagon and pancreatic-duodenal homeobox gene-1 was detected, whereas the expression of nestin and neurogenin 3 disappeared in these cells treated with serum-free media supplemented with the cocktail of growth factors. Furthermore, the intra-cellular insulin content was detected by RIA after the induction culture. CONCLUSION: Nestin-positive cells isolated from human fetal pancreas possess the characteristics of pancreatic progenitor cells since they have highly proliferative potential and the capability of differentiation into insulin-producing cells in vitro. Interestingly, the nestin-positive pancreatic progenitor cells share many phenotypic markers with mesenchymal stem cells derived from bone marrow.
AIM: To isolate nestin-positive progenitor cells from human fetal pancreas and to detect their surface markers and their capability of proliferation and differentiation into pancreatic islet endocrine cells in vitro. METHODS: Islet-like cell clusters (ICCs) were isolated from human fetal pancreas by using collagenase digestion. The free-floating ICCs were handpicked and cultured in a new dish. After the ICCs developed into monolayer epithelium-like cells, they were passaged and induced for differentiation. Reverse transcription polymerase chain reaction (RT-PCR), immunofluorescence stain, fluorescence-activated cell sorting (FACS) and radioimmunoassay (RIA) were used to detect the expression of cell markers. RESULTS: (1) The monolayer epithelium-like cells had highly proliferative potential and could be passaged more than 16 times in vitro; (2) RT-PCR analysis and immunofluorescence stain showed that these cells expressed both nestin and ABCG2, two of stem cell markers; (3) FACS analysis revealed that CD44, CD90 and CD147 were positive, whereas CD34, CD38, CD45, CD71, CD117, CD133 and HLA-DR were negative on the nestin-positive cells; (4) RT-PCR analysis showed that the mRNA expression of insulin, glucagon and pancreatic-duodenal homeobox gene-1 was detected, whereas the expression of nestin and neurogenin 3 disappeared in these cells treated with serum-free media supplemented with the cocktail of growth factors. Furthermore, the intra-cellular insulin content was detected by RIA after the induction culture. CONCLUSION: Nestin-positive cells isolated from human fetal pancreas possess the characteristics of pancreatic progenitor cells since they have highly proliferative potential and the capability of differentiation into insulin-producing cells in vitro. Interestingly, the nestin-positive pancreatic progenitor cells share many phenotypic markers with mesenchymal stem cells derived from bone marrow.
Authors: Andrée M Hierlihy; Patrick Seale; Corrinne G Lobe; Michael A Rudnicki; Lynn A Megeney Journal: FEBS Lett Date: 2002-10-23 Impact factor: 4.124
Authors: M A Goodell; M Rosenzweig; H Kim; D F Marks; M DeMaria; G Paradis; S A Grupp; C A Sieff; R C Mulligan; R P Johnson Journal: Nat Med Date: 1997-12 Impact factor: 53.440
Authors: Rohan K Humphrey; Nathan Bucay; Gillian M Beattie; Ana Lopez; Conrad A Messam; Vincenzo Cirulli; Alberto Hayek Journal: Diabetes Date: 2003-10 Impact factor: 9.461
Authors: Mary Kay Treutelaar; Jennifer M Skidmore; Claudia L Dias-Leme; Manami Hara; Lizhi Zhang; Diane Simeone; Donna M Martin; Charles F Burant Journal: Diabetes Date: 2003-10 Impact factor: 9.461
Authors: Przemyslaw Blyszczuk; Jaroslaw Czyz; Gabriela Kania; Martin Wagner; Ursula Roll; Luc St-Onge; Anna M Wobus Journal: Proc Natl Acad Sci U S A Date: 2003-01-13 Impact factor: 11.205
Authors: Claudia Merkwitz; Tiina Pessa-Morikawa; Paul Lochhead; Gessner Reinhard; Michiharu Sakurai; Antti Iivanainen; Albert M Ricken Journal: Histochem Cell Biol Date: 2011-01-04 Impact factor: 4.304
Authors: Adel Ersek; John S Pixley; A Daisy Goodrich; Christopher D Porada; Graca Almeida-Porada; David S Thain; Esmail D Zanjani Journal: Exp Hematol Date: 2010-02-17 Impact factor: 3.084